Inrig Jula 4
4 · Travere Therapeutics, Inc. · Filed Jul 2, 2025
Insider Transaction Report
Form 4
Inrig Jula
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2025-07-01$14.65/sh−815$11,940→ 88,787 total
Footnotes (1)
- [F1]This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of additional shares to cover the tax obligation that occurred upon the vesting of performance-based restricted stock units (PSUs) that vested in February 2025.